Inify Laboratories continued to deliver strong growth with sales of SEK 3.6 million in the quarter – up 62% compared to Q1. By the end of June, the laboratory had been open for over a year and had diagnosed more than 1,000 patients.
More details about the laboratory operations and its success factors are discussed in a panel talk led by Ole Eikeland with Inify's CEO Fredrik Palm and Laboratory Director Emelie Edvigsson.
Link to the panel talk is available here.
For more information, contact CEO Fredrik Palm, , or visit https://www.inify.com.